The three potentially blinding eye conditions included NAION, papillitis, and paracentral acute middle maculopathy
Lage, Glucagon-like peptide-1 receptor agonist use and renal impairment: a retrospective analysis of an electronic health records database in the U.S
The images or other third party material in this article are included in the articles Creative Commons license, unless indicated otherwise in the credit line
Some patients may maintain significant weight loss without ongoing medication, but others may struggle because obesity is a chronic metabolic condition
It is especially relevant for patients taking or researching semaglutide, tirzepatide, GLP-1 injections, oral GLP-1 options, or physician-supervised weight loss programs